Clinical Trial

HUTT to Assess Cardiac Autonomic Nervous Function

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 26, 2024 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
Autonomic nervous system diseases can cause abnormalities in the circulatory system, leading to malignant arrhythmia and sudden cardiac death. Standardized, operable, and simplified diagnostic indicators are urgently needed to evaluate autonomic nervous function, particularly cardiac autonomic nervous function. The investigators use HUTT in order to provide data support for cardiac autonomic nervous system evaluation.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-01-24.
Status change: Not Yet Recruiting → Recruiting 2024-09-24
Trial Details
NCT Number NCT06236945
Lead Sponsor The First Hospital of Hebei Medical University
Conditions Autonomic Nervous System Diseases
Enrollment 1,122 participants
Start Date 2024-01-31
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-09-26